Signaling pathways
-
BA8807 BCR-ABL-IN-8Summary: An inhibitor containing trimethoxy (trimethoxygroup). -
BA8809 AKE-72Summary: AKE-72 is a potent inhibitor. -
BA8810 HG-7-86-01Summary: HG-7-86-01 is a type II tyrosine kinase inhibitor. -
BA8811 CHMFL-BMX-078Summary: CHMFL-BMX-078 is a potent, selective, irreversible, type II kinase inhibitor. -
BA8812 TilfrinibSummary: Tilfrinib is a potent and selective inhibitor. -
BA8813 SB-633825Summary: SB-633825 is a potent, ATP-competitive inhibitor. -
BA8814 XMU-MP-2Summary: XMU-MP-2 is an inhibitor with significant inhibitory activity against BRK-positive cells. -
BA8815 EvobrutinibSummary: Evobrutinib (M2951) is an orally effective, highly selective, irreversible covalent inhibitor of... -
BA8816 KIN-8194Summary: KIN-8194 is a dual inhibitor with oral activity. -
BA8817 RemibrutinibSummary: Remibrutinib is an inhibitor with orally potent activity.

